Redington Limited Internal Restructuring Complete within Turkish Subsidiary Arena
Redington Limited announced the completion of an internal restructuring scheme involving its Turkish stepdown subsidiary, Arena. The…
Nykaa (FSN E-Commerce Ventures) Q3 FY26 Results Showcase 27% Revenue Growth and Record EBITDA Margin
FSN E-Commerce Ventures (Nykaa) reported a strong third quarter for FY26, achieving 27% year-on-year growth in net revenue, reaching INR 2,873…
Ceigall India Limited Secures ₹1,700 Crore Solar Power Project Development Contract
Ceigall India Limited has received a Letter of Award (LOA) from Rewa Ultra Mega Solar Limited for developing Unit 1 (220 MW) at Morena Solar…
Balu Forge Industries Allotment of 1 Million Equity Shares Following Warrant Conversion
Balu Forge Industries approved the allotment of 10,00,000 Equity Shares on February 9, 2026, resulting from the exercise of Convertible…
Aurobindo Pharma Board Approves Merger of Two Wholly Owned Subsidiaries
The Board of Directors of Aurobindo Pharma Limited has sanctioned a Scheme of Amalgamation involving two wholly owned subsidiaries: Auro…
Gulf Oil Lubricants India Limited Board Approves Unaudited Financial Results and Declares Interim Dividend of ₹21 per Share
Gulf Oil Lubricants India Limited announced the outcome of its Board meeting held on February 9, 2026. The Board approved the Unaudited…
AUROBINDO PHARMA Stake Acquisition in Solar Power Generator Approved for Rs 66 Crores
Aurobindo Pharma’s Board of Directors has approved an investment of Rs. 66 crores to acquire up to a 26% stake in Garuda Renewables…
Embassy Developments Limited Stock Option Scheme Update on Grant, Lapse, and Vesting
Embassy Developments Limited announced that its Nomination and Remuneration Committee approved the grant of 9,15,265 Stock Options (SOs) and…
Bata India Limited Unaudited Financial Results for Q3 FY2026 Show Strong Profit Growth
Bata India Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported a…
Aurobindo Pharma Strong Growth in Q3FY26 Driven by Europe and Stable US Performance
Aurobindo Pharma reported robust financial results for the third quarter of FY26 (Q3FY26), achieving a consolidated revenue of ₹8,646 Cr,…